• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人源和大鼠源糜蛋白酶对血管紧张素I的转化作用

Angiotensin I conversion by human and rat chymotryptic proteinases.

作者信息

Wintroub B U, Schechter N B, Lazarus G S, Kaempfer C E, Schwartz L B

出版信息

J Invest Dermatol. 1984 Nov;83(5):336-9. doi: 10.1111/1523-1747.ep12264144.

DOI:10.1111/1523-1747.ep12264144
PMID:6092480
Abstract

Human skin chymotrypsin-like proteinase, human neutrophil cathepsin G, rat mast cell chymase, and rat salivary gland tonin are cell-derived serine proteinases of similar size with specificity for amino acids of aromatic residues. Each enzyme was examined for its ability to convert angiotension I to angiotensin II and to cleave a panel of synthetic substrates. Skin chymotryptic proteinase, cathepsin G, and tonin cleaved the phe8-his9 bond of angiotensin I and converted angiotensin I to angiotensin II without further degradation. In contrast, chymase formed relatively small amounts of angiotensin II because it preferentially cleaved the tyr4-ile5 bond of angiotensin I. The rank order of angiotensin I converting activity was skin chymotryptic proteinase greater than tonin greater than cathepsin G greater than chymase. The Km and Kcat for angiotensin I conversion by the human skin enzyme were 6.6 X 10(-5) M and 50 s-1, respectively. The angiotensin I converting activity of human skin chymotryptic proteinase is equal to or greater than the peptidyl dicarboxypeptidase angiotensin-converting enzyme. Substrate specificities of each enzyme were further distinguished by use of benzoyl-L-tyrosine ethyl ester. A limited immunologic characterization of each enzyme was performed with monospecific goat antiserum to cathepsin G and chymase by Ochterlony gel diffusion. Each antiserum gave a precipitin line against its respective immunogen without evidence of cross-reactivity against the other enzymes. Human skin chymotryptic proteinase, cathepsin G, and tonin provide unique pathways for the generation of angiotensin II in tissue and may be of significance in regulation of biologic processes of the tissue microenvironment. The kinetic constants of the human skin chymotryptic proteinase for angiotensin I conversion, are consistent with the potential to carry out a reaction of physiologic importance.

摘要

人皮肤类胰凝乳蛋白酶样蛋白酶、人中性粒细胞组织蛋白酶G、大鼠肥大细胞糜酶和大鼠唾液腺血管紧张肽原酶是细胞衍生的丝氨酸蛋白酶,大小相似,对芳香族氨基酸残基具有特异性。研究了每种酶将血管紧张素I转化为血管紧张素II以及切割一组合成底物的能力。皮肤胰凝乳蛋白酶样蛋白酶、组织蛋白酶G和血管紧张肽原酶切割血管紧张素I的苯丙氨酸8-组氨酸9键,将血管紧张素I转化为血管紧张素II,且无进一步降解。相比之下,糜酶形成的血管紧张素II量相对较少,因为它优先切割血管紧张素I的酪氨酸4-异亮氨酸5键。血管紧张素I转化活性的排序为:皮肤胰凝乳蛋白酶样蛋白酶>血管紧张肽原酶>组织蛋白酶G>糜酶。人皮肤酶转化血管紧张素I的Km和Kcat分别为6.6×10⁻⁵M和50 s⁻¹。人皮肤胰凝乳蛋白酶样蛋白酶的血管紧张素I转化活性等于或大于肽基二肽羧肽酶血管紧张素转换酶。通过使用苯甲酰-L-酪氨酸乙酯进一步区分了每种酶的底物特异性。用针对组织蛋白酶G和糜酶的单特异性山羊抗血清通过奥克特洛尼凝胶扩散对每种酶进行了有限的免疫学鉴定。每种抗血清均针对其各自的免疫原产生沉淀线,没有针对其他酶的交叉反应证据。人皮肤胰凝乳蛋白酶样蛋白酶、组织蛋白酶G和血管紧张肽原酶为组织中血管紧张素II的生成提供了独特途径,可能在组织微环境的生物学过程调节中具有重要意义。人皮肤胰凝乳蛋白酶样蛋白酶转化血管紧张素I的动力学常数与进行具有生理重要性反应的潜力一致。

相似文献

1
Angiotensin I conversion by human and rat chymotryptic proteinases.人源和大鼠源糜蛋白酶对血管紧张素I的转化作用
J Invest Dermatol. 1984 Nov;83(5):336-9. doi: 10.1111/1523-1747.ep12264144.
2
Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases.中性粒细胞和肥大细胞蛋白酶将血管紧张素I快速转化为血管紧张素II。
J Biol Chem. 1982 Aug 10;257(15):8619-22.
3
Human skin chymotryptic proteinase. Isolation and relation to cathepsin g and rat mast cell proteinase I.人皮肤糜蛋白酶样蛋白酶。分离及其与组织蛋白酶G和大鼠肥大细胞蛋白酶I的关系。
J Biol Chem. 1983 Mar 10;258(5):2973-8.
4
A human lung mast cell chymotrypsin-like enzyme. Identification and partial characterization.一种人肺肥大细胞类胰凝乳蛋白酶。鉴定及部分特性研究。
J Clin Invest. 1986 Jan;77(1):196-201. doi: 10.1172/JCI112276.
5
Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell.人肥大细胞MCTC型中组织蛋白酶G样蛋白酶的鉴定。
J Immunol. 1990 Oct 15;145(8):2652-61.
6
Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart.鉴定一种高度特异性的糜蛋白酶作为人心脏中主要的血管紧张素II生成酶。
J Biol Chem. 1990 Dec 25;265(36):22348-57.
7
Mammalian chymotrypsin-like enzymes. Comparative reactivities of rat mast cell proteases, human and dog skin chymases, and human cathepsin G with peptide 4-nitroanilide substrates and with peptide chloromethyl ketone and sulfonyl fluoride inhibitors.哺乳动物类胰凝乳蛋白酶样酶。大鼠肥大细胞蛋白酶、人和犬皮肤糜蛋白酶以及人组织蛋白酶G与肽对硝基苯胺底物、肽氯甲基酮和磺酰氟抑制剂的比较反应活性。
Biochemistry. 1985 Apr 9;24(8):2048-58. doi: 10.1021/bi00329a037.
8
Inactivation of bradykinin and kallidin by cathepsin G and mast cell chymase.
Biochem Biophys Res Commun. 1985 Mar 15;127(2):443-9. doi: 10.1016/s0006-291x(85)80180-7.
9
Determination of the primary structures of human skin chymase and cathepsin G from cutaneous mast cells of urticaria pigmentosa lesions.从色素性荨麻疹皮损的皮肤肥大细胞中测定人皮肤糜蛋白酶和组织蛋白酶G的一级结构。
J Immunol. 1994 Apr 15;152(8):4062-9.
10
Angiotensin II-generating enzymes.血管紧张素II生成酶
Biochemistry (Mosc). 2000 Dec;65(12):1337-45. doi: 10.1023/a:1002848402911.

引用本文的文献

1
Is chymase 1 a therapeutic target in cardiovascular disease?糜酶 1 是否是心血管疾病的治疗靶点?
Expert Opin Ther Targets. 2023 Jul-Dec;27(8):645-656. doi: 10.1080/14728222.2023.2247561. Epub 2023 Aug 21.
2
New putative insights into neprilysin (NEP)-dependent pharmacotherapeutic role of roflumilast in treating COVID-19.新型内肽酶(NEP)依赖性罗氟司特治疗 COVID-19 的潜在药理学作用。
Eur J Pharmacol. 2020 Dec 15;889:173615. doi: 10.1016/j.ejphar.2020.173615. Epub 2020 Oct 1.
3
Chymase inhibitors for the treatment of cardiac diseases: a patent review (2010-2018).
糜酶抑制剂在治疗心脏疾病中的应用:专利研究综述(2010-2018)。
Expert Opin Ther Pat. 2018 Nov;28(11):755-764. doi: 10.1080/13543776.2018.1531848. Epub 2018 Oct 10.
4
Tracing the Origins of IgE, Mast Cells, and Allergies by Studies of Wild Animals.通过对野生动物的研究追溯免疫球蛋白E、肥大细胞和过敏的起源
Front Immunol. 2017 Dec 19;8:1749. doi: 10.3389/fimmu.2017.01749. eCollection 2017.
5
Elastase-2, an angiotensin II-generating enzyme, contributes to increased angiotensin II in resistance arteries of mice with myocardial infarction.弹性蛋白酶-2是一种生成血管紧张素II的酶,它会导致心肌梗死小鼠阻力动脉中的血管紧张素II增加。
Br J Pharmacol. 2017 May;174(10):1104-1115. doi: 10.1111/bph.13755. Epub 2017 Apr 5.
6
Targeting integrin α5β1 ameliorates severe airway hyperresponsiveness in experimental asthma.靶向整合素α5β1可改善实验性哮喘中的严重气道高反应性。
J Clin Invest. 2017 Jan 3;127(1):365-374. doi: 10.1172/JCI88555. Epub 2016 Dec 5.
7
Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.糖尿病肾病中的免疫与炎症:将机制转化为生物标志物和治疗靶点。
Am J Physiol Renal Physiol. 2017 Apr 1;312(4):F716-F731. doi: 10.1152/ajprenal.00314.2016. Epub 2016 Aug 24.
8
Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?肾素-血管紧张素系统的生化评估:益处、弊端与绝对因素?
Am J Physiol Heart Circ Physiol. 2016 Jan 15;310(2):H137-52. doi: 10.1152/ajpheart.00618.2015. Epub 2015 Oct 16.
9
Expression and activity levels of chymase in mast cells of burn wound tissues increase during the healing process in a hamster model.在仓鼠模型的烧伤创面组织愈合过程中,肥大细胞中糜酶的表达和活性水平会升高。
Exp Ther Med. 2015 Jun;9(6):2190-2194. doi: 10.3892/etm.2015.2424. Epub 2015 Apr 14.
10
Mast cell proteases as pharmacological targets.肥大细胞蛋白酶作为药理学靶点。
Eur J Pharmacol. 2016 May 5;778:44-55. doi: 10.1016/j.ejphar.2015.04.045. Epub 2015 May 7.